Regeneron Ducks Amgen's Eylea Antitrust Counterclaims
A West Virginia federal judge dismissed key counterclaims and defenses Tuesday that Amgen had raised against Regeneron's patent infringement lawsuit targeting bids by multiple would-be rivals to produce biosimilar versions of...To view the full article, register now.
Already a subscriber? Click here to view full article